Diego Ardigo | Research And Development Rare Diseases Unit Head
Chiesi Farmaceutici SpA

Diego Ardigo, Research And Development Rare Diseases Unit Head, Chiesi Farmaceutici SpA

Dr. Ardigò received his degree in Medicine and the specialization in Internal Medicine at the University of Parma (Italy). After a post-doctoral fellowship at Stanford University (California, US) he obtained a PhD degree in Cardiovascular Pathophysiology at the University of Parma. He is author of more than 40 indexed papers. He joined Chiesi in 2010 where acted as Clinical Lead in the development and registration of the first stem cell therapy in the EU (Holoclar®) and has been leading the cross-company team that led to the treatment of the first patient with a commercial gene therapy in EU (in alliance with uniQure BV). He is chairman of the Therapies Scientific Committee of IRDiRC (International Rare Diseases Research Consortium) and a member of the EBE-EFPIA ATMP Working Group.

back to speakers

There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.

There is a registration fee to attend the conferences. To visit the exhibition is free.

TO SPONSOR / EXHIBIT

Erica Baeta 
+44 (0)207 092 1152 
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson 
t/ +44 (0)207 092 1150 
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor 
+44 (0)207 092 1257 
issa.mauthoor@terrapinn.com